Sisram Medical (01696) reported no changes to its authorized share capital during the period ended 31 January 2026. The total authorized/registered share capital remains at ILS 10,000,000, consisting of 1,000,000,000 ordinary shares at a par value of ILS 0.01 each.

The total number of issued shares remains at 468,343,092, and no treasury shares were held. The issuer confirmed compliance with the minimum public float requirement of 25%. No movements occurred in share options, warrants, convertibles, or other share issuance agreements during the month.